If you have reached your target weight on tirzepatide or semaglutide and want to maintain those results without continuing injections indefinitely, orforglipron could serve as a step-down therapy
Individuals new to peptide treatments can start at a lower dosage and adjust gradually based on their response
[28] Amphetamine has also been shown to produce a conditioned place preference in humans taking therapeutic doses, [68] [132] meaning that individuals acquire a preference for spending time in places where they have previously used amphetamine
Can I switch from Rybelsus to Ozempic (or vice versa)
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin